SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3dt8'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C9S_B_TRPB81_0 (TRP RNA-BINDING ATTENUATION PROTEIN)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 9	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.30A	1c9sA-3dt8A: undetectable 1c9sB-3dt8A: undetectable	1c9sA-3dt8A: 15.02 1c9sB-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C9S_C_TRPC81_0 (TRP RNA-BINDING ATTENUATION PROTEIN)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 10	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.25A	1c9sB-3dt8A: undetectable 1c9sC-3dt8A: undetectable	1c9sB-3dt8A: 15.02 1c9sC-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C9S_H_TRPH81_0 (TRP RNA-BINDING ATTENUATION PROTEIN)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 10	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.27A	1c9sG-3dt8A: undetectable 1c9sH-3dt8A: undetectable	1c9sG-3dt8A: 15.02 1c9sH-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1D8C_A_SORA4000_0 (MALATE SYNTHASE G)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	3 / 3	GLN A 78 HIS A 79 PRO A 13	None	0.90A	1d8cA-3dt8A: undetectable	1d8cA-3dt8A: 15.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FSL_A_NIOA145_1 (LEGHEMOGLOBIN A)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	4 / 8	ILE A 96 HIS A 209 LEU A 208 VAL A 98	None	0.86A	1fslA-3dt8A: undetectable	1fslA-3dt8A: 21.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FSL_B_NIOB145_1 (LEGHEMOGLOBIN A)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	4 / 8	ILE A 96 HIS A 209 LEU A 208 VAL A 98	None	0.87A	1fslB-3dt8A: undetectable	1fslB-3dt8A: 21.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GTF_D_TRPD81_0 (TRP RNA-BINDING ATTENUATION PROTEIN (TRAP))	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 10	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.29A	1gtfC-3dt8A: undetectable 1gtfD-3dt8A: undetectable	1gtfC-3dt8A: 15.02 1gtfD-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GTF_G_TRPG81_0 (TRP RNA-BINDING ATTENUATION PROTEIN (TRAP))	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 9	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.26A	1gtfF-3dt8A: undetectable 1gtfG-3dt8A: undetectable	1gtfF-3dt8A: 15.02 1gtfG-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GTF_H_TRPH81_0 (TRP RNA-BINDING ATTENUATION PROTEIN (TRAP))	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 10	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.26A	1gtfG-3dt8A: undetectable 1gtfH-3dt8A: undetectable	1gtfG-3dt8A: 15.02 1gtfH-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GTF_I_TRPI81_0 (TRP RNA-BINDING ATTENUATION PROTEIN (TRAP))	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 10	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.28A	1gtfH-3dt8A: undetectable 1gtfI-3dt8A: undetectable	1gtfH-3dt8A: 15.02 1gtfI-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GTF_U_TRPU81_0 (TRP RNA-BINDING ATTENUATION PROTEIN (TRAP))	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 11	GLY A 116 HIS A 79 THR A 77 ILE A 117 ARG A 83	None	1.30A	1gtfU-3dt8A: undetectable 1gtfV-3dt8A: undetectable	1gtfU-3dt8A: 15.02 1gtfV-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1IIU_A_RTLA176_0 (PLASMA RETINOL-BINDING PROTEIN)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 11	LEU A 194 LEU A 139 ALA A 207 ALA A 174 TYR A 201	SGB A 47 ( 4.6A) None None None None	1.40A	1iiuA-3dt8A: undetectable	1iiuA-3dt8A: 18.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1JKH_A_EFZA999_1 (HIV-1 RT, A-CHAIN HIV-1 RT, B-CHAIN)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 11	LEU A 84 VAL A 101 GLY A 45 LEU A 81 GLU A 88	None	1.50A	1jkhA-3dt8A: 1.2 1jkhB-3dt8A: undetectable	1jkhA-3dt8A: 16.79 1jkhB-3dt8A: 17.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UTD_M_TRPM81_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 11	GLY A 116 HIS A 79 THR A 77 ILE A 117 ARG A 83	None	1.28A	1utdM-3dt8A: undetectable 1utdN-3dt8A: undetectable	1utdM-3dt8A: 15.02 1utdN-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BJW_C_SVRC505_2 (PHOSPHOLIPASE A2)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	4 / 5	VAL A 98 VAL A 97 GLN A 130 ARG A 93	None	1.32A	3bjwH-3dt8A: undetectable	3bjwH-3dt8A: 17.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BJW_G_SVRG506_2 (PHOSPHOLIPASE A2)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	4 / 5	VAL A 98 VAL A 97 GLN A 130 ARG A 93	None	1.30A	3bjwB-3dt8A: undetectable	3bjwB-3dt8A: 17.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MIH_A_CUA358_0 (PEPTIDYL-GLYCINE ALPHA-AMIDATING MONOOXYGENASE)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	3 / 3	HIS A 27 HIS A 28 MET A 24	None	0.83A	3mihA-3dt8A: undetectable	3mihA-3dt8A: 21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AZS_A_SAMA1475_1 (METHYLTRANSFERASE WBDD)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	3 / 3	ARG A 29 ASP A 20 GLN A 18	None	0.92A	4azsA-3dt8A: 3.4	4azsA-3dt8A: 17.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BBO_C_ACTC1113_0 (BLR5658 PROTEIN)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	4 / 4	ASN A 6 ALA A 8 GLY A 115 THR A 114	None	1.20A	4bboC-3dt8A: undetectable	4bboC-3dt8A: 20.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KUK_A_RBFA201_2 (BLUE-LIGHT PHOTORECEPTOR)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 9	LEU A 136 VAL A 121 ILE A 120 LEU A 84 ILE A 117	None	1.11A	4kukA-3dt8A: undetectable	4kukA-3dt8A: 21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEU_D_TRPD101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 10	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.25A	5eeuD-3dt8A: undetectable 5eeuE-3dt8A: undetectable	5eeuD-3dt8A: 15.02 5eeuE-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEU_H_TRPH101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 10	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.25A	5eeuH-3dt8A: undetectable 5eeuI-3dt8A: undetectable	5eeuH-3dt8A: 15.02 5eeuI-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEU_J_TRPJ101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 10	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.26A	5eeuJ-3dt8A: undetectable 5eeuK-3dt8A: undetectable	5eeuJ-3dt8A: 15.02 5eeuK-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEV_D_TRPD101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 10	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.24A	5eevD-3dt8A: undetectable 5eevE-3dt8A: undetectable	5eevD-3dt8A: 15.02 5eevE-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEV_J_TRPJ101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 10	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.26A	5eevJ-3dt8A: undetectable 5eevK-3dt8A: undetectable	5eevJ-3dt8A: 15.02 5eevK-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEW_D_TRPD101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 10	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.24A	5eewD-3dt8A: undetectable 5eewE-3dt8A: undetectable	5eewD-3dt8A: 15.02 5eewE-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEW_H_TRPH101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 10	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.25A	5eewH-3dt8A: undetectable 5eewI-3dt8A: undetectable	5eewH-3dt8A: 15.02 5eewI-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEW_J_TRPJ101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 10	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.26A	5eewJ-3dt8A: undetectable 5eewK-3dt8A: undetectable	5eewJ-3dt8A: 15.02 5eewK-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEX_D_TRPD101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 10	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.24A	5eexD-3dt8A: undetectable 5eexE-3dt8A: undetectable	5eexD-3dt8A: 15.02 5eexE-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEX_H_TRPH101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 10	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.25A	5eexH-3dt8A: undetectable 5eexI-3dt8A: undetectable	5eexH-3dt8A: 15.02 5eexI-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEX_I_TRPI101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 11	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.29A	5eexI-3dt8A: undetectable 5eexJ-3dt8A: undetectable	5eexI-3dt8A: 15.02 5eexJ-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEX_J_TRPJ101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 10	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.26A	5eexJ-3dt8A: undetectable 5eexK-3dt8A: undetectable	5eexJ-3dt8A: 15.02 5eexK-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEY_D_TRPD101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 10	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.24A	5eeyD-3dt8A: undetectable 5eeyE-3dt8A: undetectable	5eeyD-3dt8A: 15.02 5eeyE-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEY_I_TRPI101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 11	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.29A	5eeyI-3dt8A: undetectable 5eeyJ-3dt8A: undetectable	5eeyI-3dt8A: 15.02 5eeyJ-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEY_J_TRPJ101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 10	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.26A	5eeyJ-3dt8A: undetectable 5eeyK-3dt8A: undetectable	5eeyJ-3dt8A: 15.02 5eeyK-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEZ_D_TRPD101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 10	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.24A	5eezD-3dt8A: undetectable 5eezE-3dt8A: undetectable	5eezD-3dt8A: 15.02 5eezE-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEZ_I_TRPI101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 11	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.29A	5eezI-3dt8A: undetectable 5eezJ-3dt8A: undetectable	5eezI-3dt8A: 15.02 5eezJ-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EF0_D_TRPD101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 10	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.24A	5ef0D-3dt8A: undetectable 5ef0E-3dt8A: undetectable	5ef0D-3dt8A: 15.02 5ef0E-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EF0_I_TRPI101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 11	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.29A	5ef0I-3dt8A: undetectable 5ef0J-3dt8A: undetectable	5ef0I-3dt8A: 15.02 5ef0J-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EF1_D_TRPD101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 10	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.24A	5ef1D-3dt8A: undetectable 5ef1E-3dt8A: undetectable	5ef1D-3dt8A: 15.02 5ef1E-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EF1_I_TRPI101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 11	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.28A	5ef1I-3dt8A: undetectable 5ef1J-3dt8A: undetectable	5ef1I-3dt8A: 15.02 5ef1J-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EF2_D_TRPD101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 10	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.24A	5ef2D-3dt8A: undetectable 5ef2E-3dt8A: undetectable	5ef2D-3dt8A: 15.02 5ef2E-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EF2_I_TRPI101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 11	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.28A	5ef2I-3dt8A: undetectable 5ef2J-3dt8A: undetectable	5ef2I-3dt8A: 15.02 5ef2J-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EF3_D_TRPD101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 10	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.24A	5ef3D-3dt8A: undetectable 5ef3E-3dt8A: undetectable	5ef3D-3dt8A: 15.02 5ef3E-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EF3_I_TRPI101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 11	ARG A 83 GLY A 116 HIS A 79 THR A 77 ILE A 117	None	1.28A	5ef3I-3dt8A: undetectable 5ef3J-3dt8A: undetectable	5ef3I-3dt8A: 15.02 5ef3J-3dt8A: 15.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KOC_A_SAMA401_0 (PAVINE N-METHYLTRANSFERASE)	3dt8	BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA (Bos taurus)	5 / 12	GLY A 137 VAL A 98 VAL A 204 ALA A 207 LEU A 208	None	1.04A	5kocA-3dt8A: undetectable	5kocA-3dt8A: 19.42

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1C9S_B_TRPB81_0","TRP RNA-BINDING ATTENUATION PROTEIN","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.30A","1c9sA-3dt8A:undetectable;1c9sB-3dt8A:undetectable","1c9sA-3dt8A:15.02;1c9sB-3dt8A:15.02"],["1C9S_C_TRPC81_0","TRP RNA-BINDING ATTENUATION PROTEIN","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.25A","1c9sB-3dt8A:undetectable;1c9sC-3dt8A:undetectable","1c9sB-3dt8A:15.02;1c9sC-3dt8A:15.02"],["1C9S_H_TRPH81_0","TRP RNA-BINDING ATTENUATION PROTEIN","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.27A","1c9sG-3dt8A:undetectable;1c9sH-3dt8A:undetectable","1c9sG-3dt8A:15.02;1c9sH-3dt8A:15.02"],["1D8C_A_SORA4000_0","MALATE SYNTHASE G","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",3,"GLN A  78;HIS A  79;PRO A  13","None","0.90A","1d8cA-3dt8A:undetectable","1d8cA-3dt8A:15.35"],["1FSL_A_NIOA145_1","LEGHEMOGLOBIN A","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",4,"ILE A  96;HIS A 209;LEU A 208;VAL A  98","None","0.86A","1fslA-3dt8A:undetectable","1fslA-3dt8A:21.46"],["1FSL_B_NIOB145_1","LEGHEMOGLOBIN A","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",4,"ILE A  96;HIS A 209;LEU A 208;VAL A  98","None","0.87A","1fslB-3dt8A:undetectable","1fslB-3dt8A:21.46"],["1GTF_D_TRPD81_0","TRP RNA-BINDING ATTENUATION PROTEIN (TRAP)","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.29A","1gtfC-3dt8A:undetectable;1gtfD-3dt8A:undetectable","1gtfC-3dt8A:15.02;1gtfD-3dt8A:15.02"],["1GTF_G_TRPG81_0","TRP RNA-BINDING ATTENUATION PROTEIN (TRAP)","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.26A","1gtfF-3dt8A:undetectable;1gtfG-3dt8A:undetectable","1gtfF-3dt8A:15.02;1gtfG-3dt8A:15.02"],["1GTF_H_TRPH81_0","TRP RNA-BINDING ATTENUATION PROTEIN (TRAP)","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.26A","1gtfG-3dt8A:undetectable;1gtfH-3dt8A:undetectable","1gtfG-3dt8A:15.02;1gtfH-3dt8A:15.02"],["1GTF_I_TRPI81_0","TRP RNA-BINDING ATTENUATION PROTEIN (TRAP)","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.28A","1gtfH-3dt8A:undetectable;1gtfI-3dt8A:undetectable","1gtfH-3dt8A:15.02;1gtfI-3dt8A:15.02"],["1GTF_U_TRPU81_0","TRP RNA-BINDING ATTENUATION PROTEIN (TRAP)","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"GLY A 116;HIS A  79;THR A  77;ILE A 117;ARG A  83","None","1.30A","1gtfU-3dt8A:undetectable;1gtfV-3dt8A:undetectable","1gtfU-3dt8A:15.02;1gtfV-3dt8A:15.02"],["1IIU_A_RTLA176_0","PLASMA RETINOL-BINDING PROTEIN","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"LEU A 194;LEU A 139;ALA A 207;ALA A 174;TYR A 201","SGB A  47 ( 4.6A);None;None;None;None","1.40A","1iiuA-3dt8A:undetectable","1iiuA-3dt8A:18.80"],["1JKH_A_EFZA999_1","HIV-1 RT, A-CHAIN;HIV-1 RT, B-CHAIN","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"LEU A  84;VAL A 101;GLY A  45;LEU A  81;GLU A  88","None","1.50A","1jkhA-3dt8A:1.2;1jkhB-3dt8A:undetectable","1jkhA-3dt8A:16.79;1jkhB-3dt8A:17.77"],["1UTD_M_TRPM81_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"GLY A 116;HIS A  79;THR A  77;ILE A 117;ARG A  83","None","1.28A","1utdM-3dt8A:undetectable;1utdN-3dt8A:undetectable","1utdM-3dt8A:15.02;1utdN-3dt8A:15.02"],["3BJW_C_SVRC505_2","PHOSPHOLIPASE A2;PHOSPHOLIPASE A2","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",4,"VAL A  98;VAL A  97;GLN A 130;ARG A  93","None","1.32A","3bjwH-3dt8A:undetectable","3bjwH-3dt8A:17.16"],["3BJW_G_SVRG506_2","PHOSPHOLIPASE A2;PHOSPHOLIPASE A2","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",4,"VAL A  98;VAL A  97;GLN A 130;ARG A  93","None","1.30A","3bjwB-3dt8A:undetectable","3bjwB-3dt8A:17.16"],["3MIH_A_CUA358_0","PEPTIDYL-GLYCINE ALPHA-AMIDATING MONOOXYGENASE","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",3,"HIS A  27;HIS A  28;MET A  24","None","0.83A","3mihA-3dt8A:undetectable","3mihA-3dt8A:21.88"],["4AZS_A_SAMA1475_1","METHYLTRANSFERASE WBDD","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",3,"ARG A  29;ASP A  20;GLN A  18","None","0.92A","4azsA-3dt8A:3.4","4azsA-3dt8A:17.02"],["4BBO_C_ACTC1113_0","BLR5658 PROTEIN","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",4,"ASN A   6;ALA A   8;GLY A 115;THR A 114","None","1.20A","4bboC-3dt8A:undetectable","4bboC-3dt8A:20.10"],["4KUK_A_RBFA201_2","BLUE-LIGHT PHOTORECEPTOR","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"LEU A 136;VAL A 121;ILE A 120;LEU A  84;ILE A 117","None","1.11A","4kukA-3dt8A:undetectable","4kukA-3dt8A:21.43"],["5EEU_D_TRPD101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.25A","5eeuD-3dt8A:undetectable;5eeuE-3dt8A:undetectable","5eeuD-3dt8A:15.02;5eeuE-3dt8A:15.02"],["5EEU_H_TRPH101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.25A","5eeuH-3dt8A:undetectable;5eeuI-3dt8A:undetectable","5eeuH-3dt8A:15.02;5eeuI-3dt8A:15.02"],["5EEU_J_TRPJ101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.26A","5eeuJ-3dt8A:undetectable;5eeuK-3dt8A:undetectable","5eeuJ-3dt8A:15.02;5eeuK-3dt8A:15.02"],["5EEV_D_TRPD101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.24A","5eevD-3dt8A:undetectable;5eevE-3dt8A:undetectable","5eevD-3dt8A:15.02;5eevE-3dt8A:15.02"],["5EEV_J_TRPJ101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.26A","5eevJ-3dt8A:undetectable;5eevK-3dt8A:undetectable","5eevJ-3dt8A:15.02;5eevK-3dt8A:15.02"],["5EEW_D_TRPD101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.24A","5eewD-3dt8A:undetectable;5eewE-3dt8A:undetectable","5eewD-3dt8A:15.02;5eewE-3dt8A:15.02"],["5EEW_H_TRPH101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.25A","5eewH-3dt8A:undetectable;5eewI-3dt8A:undetectable","5eewH-3dt8A:15.02;5eewI-3dt8A:15.02"],["5EEW_J_TRPJ101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.26A","5eewJ-3dt8A:undetectable;5eewK-3dt8A:undetectable","5eewJ-3dt8A:15.02;5eewK-3dt8A:15.02"],["5EEX_D_TRPD101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.24A","5eexD-3dt8A:undetectable;5eexE-3dt8A:undetectable","5eexD-3dt8A:15.02;5eexE-3dt8A:15.02"],["5EEX_H_TRPH101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.25A","5eexH-3dt8A:undetectable;5eexI-3dt8A:undetectable","5eexH-3dt8A:15.02;5eexI-3dt8A:15.02"],["5EEX_I_TRPI101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.29A","5eexI-3dt8A:undetectable;5eexJ-3dt8A:undetectable","5eexI-3dt8A:15.02;5eexJ-3dt8A:15.02"],["5EEX_J_TRPJ101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.26A","5eexJ-3dt8A:undetectable;5eexK-3dt8A:undetectable","5eexJ-3dt8A:15.02;5eexK-3dt8A:15.02"],["5EEY_D_TRPD101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.24A","5eeyD-3dt8A:undetectable;5eeyE-3dt8A:undetectable","5eeyD-3dt8A:15.02;5eeyE-3dt8A:15.02"],["5EEY_I_TRPI101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.29A","5eeyI-3dt8A:undetectable;5eeyJ-3dt8A:undetectable","5eeyI-3dt8A:15.02;5eeyJ-3dt8A:15.02"],["5EEY_J_TRPJ101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.26A","5eeyJ-3dt8A:undetectable;5eeyK-3dt8A:undetectable","5eeyJ-3dt8A:15.02;5eeyK-3dt8A:15.02"],["5EEZ_D_TRPD101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.24A","5eezD-3dt8A:undetectable;5eezE-3dt8A:undetectable","5eezD-3dt8A:15.02;5eezE-3dt8A:15.02"],["5EEZ_I_TRPI101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.29A","5eezI-3dt8A:undetectable;5eezJ-3dt8A:undetectable","5eezI-3dt8A:15.02;5eezJ-3dt8A:15.02"],["5EF0_D_TRPD101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.24A","5ef0D-3dt8A:undetectable;5ef0E-3dt8A:undetectable","5ef0D-3dt8A:15.02;5ef0E-3dt8A:15.02"],["5EF0_I_TRPI101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.29A","5ef0I-3dt8A:undetectable;5ef0J-3dt8A:undetectable","5ef0I-3dt8A:15.02;5ef0J-3dt8A:15.02"],["5EF1_D_TRPD101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.24A","5ef1D-3dt8A:undetectable;5ef1E-3dt8A:undetectable","5ef1D-3dt8A:15.02;5ef1E-3dt8A:15.02"],["5EF1_I_TRPI101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.28A","5ef1I-3dt8A:undetectable;5ef1J-3dt8A:undetectable","5ef1I-3dt8A:15.02;5ef1J-3dt8A:15.02"],["5EF2_D_TRPD101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.24A","5ef2D-3dt8A:undetectable;5ef2E-3dt8A:undetectable","5ef2D-3dt8A:15.02;5ef2E-3dt8A:15.02"],["5EF2_I_TRPI101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.28A","5ef2I-3dt8A:undetectable;5ef2J-3dt8A:undetectable","5ef2I-3dt8A:15.02;5ef2J-3dt8A:15.02"],["5EF3_D_TRPD101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.24A","5ef3D-3dt8A:undetectable;5ef3E-3dt8A:undetectable","5ef3D-3dt8A:15.02;5ef3E-3dt8A:15.02"],["5EF3_I_TRPI101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"ARG A  83;GLY A 116;HIS A  79;THR A  77;ILE A 117","None","1.28A","5ef3I-3dt8A:undetectable;5ef3J-3dt8A:undetectable","5ef3I-3dt8A:15.02;5ef3J-3dt8A:15.02"],["5KOC_A_SAMA401_0","PAVINE N-METHYLTRANSFERASE","3dt8","BRAIN PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IB SUBUNIT ALPHA","Bos taurus",5,"GLY A 137;VAL A  98;VAL A 204;ALA A 207;LEU A 208","None","1.04A","5kocA-3dt8A:undetectable","5kocA-3dt8A:19.42"]]